https://lonidaminemodulator.co....m/tuning-in-within-c
Until recently just initial phases of ATTRv-PN (polyneuropathy) had accessibility disease-modifying therapy (DMT), whereas there was no specific treatment plan for ATTRv-CM (cardiomyopathy). This review updates our information about results of three period 3 medical trials, expert's consensus for early diagnosis and emerging biomarkers. Two period 3 researches utilizing RNAi and antisense oligonucleotides (ASO) had been effective. Primary endpoints had been development of neuropathic score mNIS +7 and qual
Like
Comment
Share
